scispace - formally typeset
H

Howard I. Hurtig

Researcher at University of Pennsylvania

Publications -  142
Citations -  27820

Howard I. Hurtig is an academic researcher from University of Pennsylvania. The author has contributed to research in topics: Dementia & Parkinson's disease. The author has an hindex of 68, co-authored 140 publications receiving 24232 citations. Previous affiliations of Howard I. Hurtig include Graduate Hospital & Avid Radiopharmaceuticals.

Papers
More filters
Journal ArticleDOI

Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results.

Christopher G. Goetz, +87 more
- 15 Nov 2008 - 
TL;DR: The combined clinimetric results of this study support the validity of the MDS‐UPDRS for rating PD.
Journal ArticleDOI

MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging

TL;DR: The frequently observed "halo" of periventricular hyperintensity in Alzheimer's disease may be of diagnostic importance and high-signal abnormalities in specific cortical regions are likely to reflect disease processes localized to those structures.
Journal Article

MR Signal Abnormalities at 1.5 T in Alzheimer's Dementia and Normal Aging

TL;DR: The type, frequency, and extent of MR signal abnormalities in Alzheimer9s disease and normal aging are a subject of controversy as mentioned in this paper, and the most commonly observed "halo" of periventricular hyperintensity in Alzheimer 9s disease may be of diagnostic importance.
Journal ArticleDOI

Oxidative Damage Linked to Neurodegeneration by Selective α-Synuclein Nitration in Synucleinopathy Lesions

TL;DR: The selective and specific nitration of alpha-synuclein in these disorders provides evidence to directly link oxidative and nitrative damage to the onset and progression of neurodegenerative synucleinopathies.
Journal ArticleDOI

Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson’s disease

TL;DR: CLBs detected by α-synuclein antibodies in patients with PD are a more sensitive and specific correlate of dementia than the presence of Alzheimer’s pathology, which was present in a minority of the cases in this series.